92 results
Page 3 of 5
424B5
29qt2t9 do2
6 Aug 20
Prospectus supplement for primary offering
5:17pm
8-K
vu79991dnr3ci8
13 Mar 20
Departure of Directors or Certain Officers
4:05pm
424B5
p9r8cvx 353c
23 Jan 20
Prospectus supplement for primary offering
4:44pm
424B5
6cbk63uv9gm0e ssti
22 Jan 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-10.1
41kijqam6a wz5r
2 Dec 19
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy
7:52am
424B5
0p9m s3zo8o6v
5 Nov 19
Prospectus supplement for primary offering
5:16pm
8-K
EX-10.2
sym oldp3dedg
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
7f4h65z
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.3
f2z30knw64j
25 Mar 19
Departure of Directors or Certain Officers
4:30pm